Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical TechnologiesNSE:AAKAAR -4.94%20 Return-on-Tangible-Equity is 29.35% as of Mar. 2026, which is 20% above its 10-year median of 24.36. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks better than 77.84% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aakaar Medical Technologies's annualized net income for the quarter that ended in Mar. 2026 was ₹148.4 Mil. Aakaar Medical Technologies's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹505.8 Mil. Therefore, Aakaar Medical Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 29.35%.
The historical rank and industry rank for Aakaar Medical Technologies's Return-on-Tangible-Equity or its related term are showing as below:
NSE:AAKAAR'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 16.01 Med: 24.36 Max: 33.72
Current: 16.01
During the past 5 years, Aakaar Medical Technologies's highest Return-on-Tangible-Equity was 33.72%. The lowest was 16.01%. And the median was 24.36%.
NSE:AAKAAR's Return-on-Tangible-Equity is ranked better than 77.84% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.055
vs NSE:AAKAAR: 16.01
Aakaar Medical Technologies (NSE:AAKAAR) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aakaar Medical Technologies Return-on-Tangible-Equity Related Terms
Aakaar Medical Technologies Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aakaar Medical Technologies Return-on-Tangible-Equity Chart
NSE:AAKAAR vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Aakaar Medical Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aakaar Medical Technologies Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aakaar Medical Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 29.35% mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Return-on-Tangible-Equity of 29.35% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aakaar Medical Technologies and its competitors. This is 20% above median its historical median of 24.36. Over the past decade, Aakaar Medical Technologies' Return-on-Tangible-Equity has ranged from 16.01 to 33.72. According to the industry distribution chart, Aakaar Medical Technologies ranks #168 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 22.2%.
Is Aakaar Medical Technologies' Return-on-Tangible-Equity too high?
Aakaar Medical Technologies' current Return-on-Tangible-Equity of 29.35% is 20% above median its 10-year median of 24.36. Over the past 10 years, this metric has ranged from a low of 16.01 to a high of 33.72. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.06. Aakaar Medical Technologies' value of 29.35% is 623.8% above this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #168 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #168 out of 758 companies for Return-on-Tangible-Equity. This places Aakaar Medical Technologies in the top 22% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.06. Aakaar Medical Technologies' value of 29.35% is 623.8% above this benchmark. Historically, Aakaar Medical Technologies' own Return-on-Tangible-Equity has ranged from 16.01 to 33.72 over the past decade. While the company's 10-year median is 24.36 vs. the industry median of 4.06, Aakaar Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current Return-on-Tangible-Equity of 29.35% is 623.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current Return-on-Tangible-Equity is 29.35%, which is 20% above median its own 10-year median of 24.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Return-on-Tangible-Equity of 29.35%. The current Return-on-Tangible-Equity is 29.35%, which is 20% above median its 10-year median of 24.36 and 623.8% above the Medical Devices & Instruments industry median of 4.06. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Return-on-Tangible-Equity is 29.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score
Get the complete analysis for NSE:AAKAAR
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
